Skip to content

Comprehensive Textbook of Genitourinary Oncology

ISBN-10: 0683085999

ISBN-13: 9780683085990

Edition: 1996

Authors: Nicholas J. Vogelzang, Brian J. Miles

List price: $179.95
Blue ribbon 30 day, 100% satisfaction guarantee!
what's this?
Rush Rewards U
Members Receive:
Carrot Coin icon
XP icon
You have reached 400 XP and carrot coins. That is the daily max!

Description:

Thoroughly revised for its Third Edition, this volume is the most comprehensive, multidisciplinary text on genitourinary cancers. This edition has two new editors Frans M.J. Debruyne and W. Marston Linehan and more than 50% new contributors. Seventeen new chapters cover familial prostate cancer, biology of bone metastases, molecular pathology and biologic determinants, PSA and related kallikreins, needle biopsy, laparoscopic surgical procedures, 3D conformal radiotherapy, hormones and radiotherapy, integration of chemotherapy and other modalities, quality of life after treatment of localized prostate cancer, management of rising PSA after local therapy, the role of surgery in advanced bladder cancer, post-chemotherapy node dissections and resection of metastatic disease, and stem cell transplantation.
Customers also bought

Book details

List price: $179.95
Copyright year: 1996
Publisher: Lippincott Williams & Wilkins
Binding: Paperback
Pages: 928
Language: English

Preface
Contributors
Reviewing the Genitourinary Oncology Literaturep. 1
The Principles of Sample Size Computationp. 8
Analyzing Health-Related Quality of Lifep. 15
Quantitative Approaches to Diagnostic Testing and Decision Making in Genitourinary Oncologyp. 21
Cancer Patient Support and Advocacyp. 33
Pain Control in Genitourinary Malignanciesp. 40
Supporting the Patient with Genitourinary Cancer: The Role of the Social Workerp. 43
Oncology Nursing Practice in the Care of Genitourinary Cancer Patientsp. 48
Hospice Carep. 54
Anemia and Transfusionsp. 57
Nutrition Support and Cachexiap. 60
Prevention of Urologic Malignanciesp. 64
Molecular Genetics and Cell Biologyp. 68
Molecular Pharmacology: Opportunities for Enhancement of Antineoplastic Therapiesp. 80
Wilms' Tumorsp. 89
Neuroblastoma: Natural History and Current Therapeutic Approachesp. 98
The Management of Pediatric Genitourinary Rhabdomyosarcomap. 108
Testicular, Sacrococcygeal, and Other Tumorsp. 115
Management of Adrenal Neoplasmsp. 125
Clinical Signs and Symptoms of Renal Cell Carcinomap. 154
Molecular Genetics of Renal Cell Carcinomap. 160
Immunology of Renal Cell Carcinomap. 171
Classification of Renal Cell Carcinoma: Correlation of Morphology and Cytogeneticsp. 179
Radiologic Imaging of Renal Cell Carcinoma: Its Role in Diagnosis, Staging, and Managementp. 187
Nephron-Sparing Surgery for Renal Cell Carcinomap. 207
Surgical Treatment of Locally Advanced Renal Cell Carcinomap. 218
Lymph Node Dissection in the Treatment of Renal Cell Carcinomap. 236
Immunotherapy with High-Dose Interleukin 2p. 242
Low-Dose Interleukin 2 for Advanced Renal Cell Carcinomap. 248
Management of Interleukin 2 Toxicityp. 255
Cellular and Gene Therapyp. 261
Chemotherapy, Hormonal Therapy, and Interferonsp. 275
Surgical Resection of Metastatic Diseasep. 284
The Roles of Radiation Therapy and Surgical Resection in the Management of Osseous Metastases from Renal Cell Carcinomap. 292
Clinical Signs and Symptoms of Bladder Cancerp. 295
Epidemiology of Bladder Cancerp. 298
Biochemical and Molecular Carcinogenesisp. 305
Molecular Biology of Bladder Cancerp. 314
Pathology of Bladder Cancerp. 326
Cytology of Bladder Cancerp. 338
Screening, Early Detection, and Prevention of Bladder Cancerp. 351
Staging of Bladder Cancerp. 359
Imagingp. 371
Endoscopic Managementp. 388
Surgical Managementp. 397
Natural History and Surgical Management of Superficial Bladder Cancer (Stages Ta/T1/CIS)p. 405
Management of Superficial Bladder Cancer Ta/T1/TIS: Intravesical Chemotherapyp. 416
Management of Superficial Bladder Cancer Ta/TI/TIS: Immunotherapyp. 427
Alternative Immunotherapies for Superficial Bladder Cancerp. 435
Radical Cystectomy for Bladder Cancerp. 442
Adjuvant and Neoadjuvant Chemotherapy for Invasive (T3-T4) Bladder Cancerp. 464
Urinary Diversions and Reconstruction: Introduction and Standardsp. 472
Continent Cutaneous Urinary Diversion: The Indiana Pouchp. 479
The Kock Technique for Continent Urinary Diversion and Orthotopic Bladder Replacementp. 485
Heal Low Pressure Bladder Substitute with an Afferent Tubular Isoperistaltic Segmentp. 495
The Role of Transurethral Surgery Alone and with Combined Modality Therapyp. 509
Radiation Therapy for Organ Conservation for Invasive Bladder Carcinomap. 513
Bladder-Preserving Treatments: Chemotherapy and Conservative Surgeryp. 522
Chemotherapy and Radiation Therapy with Organ Sparing in the Treatment of Invasive Bladder Cancerp. 534
Management of Metastatic Diseasep. 540
Clinical Symptoms and Signs of Prostate Cancerp. 557
Epidemiology of Prostate Cancerp. 565
Prostate Cancer in Ethnic Groupsp. 573
Molecular Genetics of Prostate Cancerp. 579
Perspectives on the Molecular Biology of Prostate Cancerp. 593
Physiology and Endocrinology of the Prostatep. 600
Anatomy of the Prostate and the Pathology of Prostate Cancerp. 621
Prostatic Intraepithelial Neoplasiap. 639
DNA Ploidy, Volume, and Other Prognostic Factorsp. 645
Neuroendocrine Differentiation in Prostate Cancerp. 652
Chemoprevention in Prostate Cancerp. 657
The Value of Molecular Forms and Age-Specific Reference Rangesp. 668
Use of PSA Density and PSA Velocityp. 680
Screening for Prostate Cancerp. 684
Prostatic Biopsyp. 699
Staging Systems and Prognostic Factors for Prostate Cancerp. 712
Imaging in Prostate Cancerp. 723
Expectant Managementp. 734
Radical Prostatectomy for Clinical Stage T1 and T2 Prostate Cancerp. 741
Radiation Therapy for Stage T1 and T2 Prostate Cancerp. 759
The Role of Radiation as Adjuvant or Salvage Therapy Following Radical Prostatectomyp. 782
The Role of Radiation Therapy in the Management of Stage T3-T4 Prostate Cancer: Rationale, Technique, and Results with Standard Radiation, Conformal Therapy, Proton and Neutron Beam Therapyp. 790
Combined Radiation Therapy and Endocrine Therapy in Locally Advanced Prostate Cancerp. 798
Primary Surgery for Clinical Stage T3 Adenocarcinoma of the Prostatep. 803
Neoadjuvant Hormonal Therapy and Radical Prostatectomy for Locally Advanced Prostate Carcinomap. 811
Salvage Radical Prostatectomy for Local Recurrence of Prostate Cancer After Radiation Therapyp. 817
Cryoablation for Prostate Cancerp. 828
Management Options for Patients with Lymph Node Metastases from Prostate Cancerp. 838
Hormonal Management of Metastatic Prostate Cancer and Quality of Life Issuesp. 854
Combined Androgen Blockadep. 875
Secondary Hormonal Manipulationp. 885
Role of Radiation Therapy in the Management of Hormone-Refractory Metastatic Prostate Cancerp. 891
Suramin in Advanced Prostate Cancerp. 897
Management of Hormone-Refractory Prostate Cancer: Chemotherapy and Newer Approachesp. 907
Neuroendocrine Progressionp. 914
Clinical Signs and Symptomsp. 921
Epidemiology of Testis Cancerp. 923
Molecular Genetics of Male Germ Cell Tumorsp. 932
Carcinoma In Situ of the Testis: A New Biological Concept of Urologic Relevance and Implications for Detection and Managementp. 941
Anatomy and Pathology of Testis Cancerp. 953
Serum Tumor Markers and Their Role in Monitoring Germ Cell Cancers of the Testisp. 968
Staging and Imaging of Testis Cancerp. 981
Radical Orchiectomyp. 992
Retroperitoneal Lymph Node Dissectionp. 996
Resection of Residual or Metastatic Diseasep. 1002
Observation and Expectant Management for Low-Stage Seminoma and Nonseminomap. 1016
Chemotherapy for Stage I and II Testis Cancerp. 1022
The Treatment of Patients with Stage I Seminoma of the Testisp. 1028
Seminoma: Management of Stage II Disease, Posttherapy Residual Masses, and Other Special Considerationsp. 1038
Overview of Initial Therapy for Metastatic Seminoma and Nonseminomap. 1050
Risk-Adapted Therapy/Good-Risk Patientsp. 1057
Poor-Risk Testis Cancerp. 1064
Extragonadal Germ Cell Tumorsp. 1070
Treatment of Recurrent Germ Cell Tumorsp. 1075
New Techniques in Autologous Marrow and Peripheral Blood Progenitor Cell Transplantsp. 1082
Late Toxicity After Chemotherapy of Testis Cancerp. 1090
Penile Cancer: Overviewp. 1097
Surgical Management for Penile Cancerp. 1103
Radiation Therapy for Penile Cancerp. 1109
Chemotherapy for Penile Cancerp. 1114
Urethral Tumorsp. 1117
Genitourinary Sarcomas in Adultsp. 1124
Malignant Lymphoma of the Genitourinary Tractp. 1140
Miscellaneous Tumors of the Genitourinary Tractp. 1152
Indexp. 1159
Table of Contents provided by Blackwell. All Rights Reserved.